Sihuan Pharmaceutical Holdings Group Ltd banner

Intrinsic Value

The intrinsic value of Sihuan Pharmaceutical Holdings Group Ltd (SHPHF) under the Base Case is 0.22 USD per share. Compared with the current market price of 0.12 USD, the stock appears Undervalued by 46% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

SHPHF Intrinsic Value
$0.22
Undervaluation 46%
Intrinsic Value
Price $0.12

SHPHF is cheaper than usual. It was this cheap or cheaper on just 2% of days in the past 5 years.

Monitor SHPHF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.18
Get notified when the price drops into your buy zone
Intrinsic Value $0.22
Margin of Safety 20% $0.18
Current Price $0.12
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to SHPHF

Fundamental Analysis

What Sihuan Pharmaceutical Holdings Group Does

Pharmaceuticals Health Care

Sihuan Pharmaceutical Holdings Group is a China-based drug company that develops, makes, and sells prescription medicines. Its core business is selling branded drugs used mainly for hospital treatment, with a focus on therapies such as cardiovascular and other chronic-care medicines. It also works on research and development to bring new products into its portfolio.

Headquarters
China CN
Employees
2 843
IPO date
Oct 28, 2010
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Sihuan Pharmaceutical Holdings Group Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one SHPHF stock?

The intrinsic value for Sihuan Pharmaceutical Holdings Group Ltd (SHPHF) under the Base Case is 0.22 USD.

Is SHPHF stock undervalued or overvalued?

Compared with the current market price of 0.12 USD, the stock appears Undervalued by 46% .

Back to Top